Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 comparison of daclatasvir vs telaprevir with peginterferon alfa-2a and ribavirin in treatment-naive chronic hepatitis C
2011-004237-14Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daclatasvir in chronic hepatitis C (CHC), sponsored by Bristol Myers Squibb. Started Dec 2011; status: completed.
02
Drugs
daclatasvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on 2011-004237-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004237-14.